======= DPY30 ======= == Gene Information == * **Official Symbol**: DPY30 * **Official Name**: dpy-30 histone methyltransferase complex regulatory subunit * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=84661|84661]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9C005|Q9C005]] * **Interactions**: [[https://thebiogrid.org/search.php?search=DPY30&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20DPY30|Open PubMed]] * **OMIM**: [[https://omim.org/entry/612032|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: As part of the MLL1/MLL complex, involved in the methylation of histone H3 at 'Lys-4', particularly trimethylation. Histone H3 'Lys-4' methylation represents a specific tag for epigenetic transcriptional activation. May play some role in histone H3 acetylation. In a teratocarcinoma cell, plays a crucial role in retinoic acid-induced differentiation along the neural lineage, regulating gene induction and H3 'Lys-4' methylation at key developmental loci. May also play an indirect or direct role in endosomal transport. {ECO:0000269|PubMed:19556245, ECO:0000269|PubMed:19651892, ECO:0000269|PubMed:21335234}. |Dpy-30| |Set1C/COMPASS complex| |MLL3/4 complex| |histone H3-K4 methylation| |histone methyltransferase complex| |regulation of megakaryocyte differentiation| |histone lysine methylation| |peptidyl-lysine methylation| |histone methylation| |protein methylation| |protein alkylation| |trans-Golgi network| |regulation of myeloid cell differentiation| |endosomal transport| |macromolecule methylation| |methylation| |peptidyl-lysine modification| |histone modification| |covalent chromatin modification| |regulation of hemopoiesis| |chromatin organization| |protein homodimerization activity| |peptidyl-amino acid modification| |Golgi apparatus| |chromosome organization| |identical protein binding| |intracellular transport| |regulation of immune system process| |regulation of cell differentiation| |establishment of localization in cell| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp287|HMS-I2 5μM R06 exp287]]|-2.26| |[[:results:exp389|PF-06409577 20μM R07 exp389]]|-1.82| |[[:results:exp160|Ribavirin 10 to 15μM on day4 R04 exp160]]|-1.72| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 2/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 792 * **Expression level (log2 read counts)**: 5.02 {{:chemogenomics:nalm6 dist.png?nolink |}}